NCT02329769 - Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 1, 2016

Study Completion Date

August 31, 2016

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG

PRO044 SC 6 mg/kg

DRUG

PRO044 IV 6 mg/kg

DRUG

PRO044 IV 9 mg/kg

Trial Locations (5)

UZ Leuven, Leuven

S.Anna Hospital, Ferrara

Policlinico Universitario Agostino Gemelli, Roma

Leids Universitair Medisch Centrum, Leiden

Drottning Silvias Barn- ochungdomssjukhus, Gothenburg